Literature DB >> 11470508

Evidence for alternate splicing within the mRNA transcript encoding the DNA damage response kinase ATR.

J L Mannino1, W Kim, M Wernick, S V Nguyen, R Braquet, A W Adamson, Z Den, M A Batzer, C C Collins, K D Brown.   

Abstract

Proper cellular response to genotoxic insult often requires the activity of one or more members of a family of high-molecular weight protein kinases referred to as phosphatidylinositol-3 kinase (PIK)-like proteins. While catalytic activity is an indispensable part of PIK-like protein function, little is currently known about factors that control their activity and/or functions. This deficiency stems, in large part, from our lack of knowledge concerning functionally significant subdomains within the large non-catalytic domain of these proteins. We have determined that the transcript encoding the PIK-like protein ATR undergoes alternate splicing within the region of the mRNA encoding its non-catalytic domain. This conclusion is based on the sequencing of a human expressed sequence tag clone encoding a portion of the ATR cDNA, and is supported by the results of reverse transcriptase-polymerase chain reaction (RT-PCR) assays conducted on total and polyA+ RNA, as well as sequencing of cloned RT-PCR products. Cloning and sequencing of a segment of human genomic DNA indicated that this event arises from splicing of a single 192 bp exon within the ATR gene. Analysis of several human tissues indicated that alternate ATR transcripts are differentially expressed, suggesting that this region of the ATR protein may be of functional importance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470508     DOI: 10.1016/s0378-1119(01)00543-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  ATR and ATRIP are recruited to herpes simplex virus type 1 replication compartments even though ATR signaling is disabled.

Authors:  Kareem N Mohni; Christine M Livingston; David Cortez; Sandra K Weller
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

2.  Functional significance for a heterogenous ribonucleoprotein A18 signature RNA motif in the 3'-untranslated region of ataxia telangiectasia mutated and Rad3-related (ATR) transcript.

Authors:  Ruiqing Yang; Ming Zhan; Narasimha Rao Nalabothula; Qingyuan Yang; Fred E Indig; France Carrier
Journal:  J Biol Chem       Date:  2010-01-26       Impact factor: 5.157

3.  Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.

Authors:  Francine Durocher; Yvan Labrie; Penny Soucy; Olga Sinilnikova; Damian Labuda; Paul Bessette; Jocelyne Chiquette; Rachel Laframboise; Jean Lépine; Bernard Lespérance; Geneviève Ouellette; Roxane Pichette; Marie Plante; Sean V Tavtigian; Jacques Simard
Journal:  BMC Cancer       Date:  2006-09-29       Impact factor: 4.430

4.  Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse.

Authors:  Derek W Wang; Ekaterina I Mokhonova; Genevieve C Kendall; Diana Becerra; Yalda B Naeini; Rita M Cantor; Melissa J Spencer; Stanley F Nelson; M Carrie Miceli
Journal:  Mol Ther Nucleic Acids       Date:  2018-02-13       Impact factor: 8.886

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.